CURA.CN - Curaleaf Holdings, Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
10.63
+0.14 (+1.33%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close10.49
Open10.18
Bid10.63 x 0
Ask10.69 x 0
Day's Range9.93 - 10.69
52 Week Range0.25 - 15.75
Volume1,193,721
Avg. Volume664,241
Market Cap4.849B
Beta (3Y Monthly)-107.70
PE Ratio (TTM)N/A
EPS (TTM)-0.19
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • 3 Cannabis Stocks That Were Just Upgraded by a Top Analyst
    The Motley Fool

    3 Cannabis Stocks That Were Just Upgraded by a Top Analyst

    Curaleaf Holdings Inc (CNSX:CURA) and these two other pot stocks look to dominate the U.S. cannabis industry.

  • Baystreet

    How Multi-State Cannabis and Hemp Operators Stand to Potentially Benefit from New Federal Banking Laws

    New banking laws could be on deck for cannabis and hemp companies operating across the United States, ...

  • CNW Group

    Curaleaf Announces Opening of New Arizona Dispensary

    PHOENIX, Sept. 18, 2019 /CNW/ -- Curaleaf Holdings, Inc. (CSE:CURA.CN - News) (OTCQX:CURLF - News) ("Curaleaf" or the "Company"), a leading vertically integrated cannabis operator in the United States, today announced the opening of its seventh dispensary in Arizona at 217 N 83rd Avenue in the Phoenix metro area. Curaleaf Pavilions is a newly developed, flagship dispensary with close access to the I-10 Freeway. "Maricopa is the fastest-growing county in the country," said Joe Lusardi, President and Chief Executive Officer of Curaleaf.

  • Market Exclusive

    Curaleaf Launches Medical Cannabis Tablets in Florida

    Curaleaf Holdings (CSE: CURA) (OTCQX: CURLF) is launching medical cannabis tablets in Florida. The medical cannabis tablets will be available in all 26 Curaleaf dispensaries across the state. Curaleaf has 49 dispensaries across the country. The company sells medical cannabis in tablet form in Connecticut, New Jersey, Maryland, and New York, with plans to launch in additional states. […]The post Curaleaf Launches Medical Cannabis Tablets in Florida appeared first on Market Exclusive.

  • CNW Group

    Curaleaf Receives Approval for Five Adult-Use Licenses in Massachusetts

    WAKEFIELD, Mass., Sept. 13, 2019 /CNW/ -- Today Curaleaf Holdings, Inc. (CSE:CURA.CN - News) (OTCQX:CURLF - News) ("Curaleaf" or the "Company"), a leading vertically integrated cannabis operator in the United States, was granted approval for its three final and two provisional adult-use licenses by the Massachusetts Cannabis Control Commission.  Following today's approval of all five licenses, the next step in the process is to schedule Post Final inspections for the three final licenses, which will then be followed by Commence Operation inspections. "We appreciate the work of the Cannabis Control Commission and the Commission staff and will continue to work collaboratively with them to move forward in securing approval on our final inspections," said Joseph Lusardi, CEO of Curaleaf.

  • CNW Group

    Curaleaf Launches First Medical Cannabis Tablets in Florida

    MIAMI, Sept. 12, 2019 /CNW/ -- Curaleaf Holdings, Inc. (CSE:CURA.CN - News) (OTCQX:CURLF - News) ("Curaleaf" or the "Company"), a leading vertically integrated cannabis operator in the United States, announced today the company is the first in Florida to launch medical cannabis tablets, available in all 26 Curaleaf dispensaries across the state. Curaleaf, operator of the largest cannabis retail footprint in the US, with 49 dispensaries across the country, also sells medical cannabis in tablet form in Connecticut, New Jersey, Maryland and New York, with plans to launch in additional states.

  • Trading Places: The Best and Worst Sectors Swap Spots in Canada
    Bloomberg

    Trading Places: The Best and Worst Sectors Swap Spots in Canada

    (Bloomberg) -- As momentum trades unravel in major stock markets across the world, investors in Canada have another rotation to watch.Tech stocks, which had been the top performing sector on the S&P/TSX Composite Index until last month, are now among the worst. Taking the No. 1 spot in September is the health-care gauge. Before you deem this a flight to safety, consider that volatile pot stocks make up more than half of the S&P/TSX Composite Health Care Index.“Things got a little bit overextended in the realm of safety,” said Hans Albrecht, fund manager at Toronto-based Horizons ETFs Management Canada Inc. “Come early September that unwound a little bit.”Part of it can be blamed on the move that investors are making from growth stocks to value as they sell out of tech and into sectors like energy and financials. But there’s also been a rebound in the shares of weed companies.It may be a technical bounce after cannabis stocks underperformed since April. “They’ve been suffering all year,” Albrecht said. “Whether there’s some sort of underlying story that will give them a big push, I’m not sure.”Pot stocks have had a rough year as leaders in the industry reported disappointing results, regulatory breaches and as acquisitions languished amid U.S. antitrust reviews. Canopy Growth Corp., up about 15% this month, was in oversold territory in August. Aurora Cannabis Inc. was flirting with that technical level for most of last month.Others point to a short squeeze. “A lot of people were shorting the companies for fundamental reasons and also quantitative reasons,” said Greg Taylor, chief investment officer at Purpose Investments.And that may be unwinding. Some U.S.-based companies have posted good earnings, like Curaleaf Holdings Inc., and that might be boosting sentiment, he said. Bank of Montreal is no longer allowing retail investors to short cannabis stocks, according to a media report. But the pot stock bounce does feel like a technical move, Taylor added.Canada’s tech stocks have added C$49 billion in value through the end of August. Since then, they have erased about C$7 billion as investors reassessed expectations for global economic growth. On the flipside, among the top companies on the health-care gauge this month are weed stocks: Canopy Growth, Aurora Cannabis, Hexo Corp., Aphria Inc. and Cronos Group Inc.“It almost feels like a change in sentiment,” Taylor said. “A lot of people have been hiding in momentum names. Some people have reversed those trades.”To contact the reporter on this story: Divya Balji in Toronto at dbalji1@bloomberg.netTo contact the editors responsible for this story: Madeleine Lim at mlim131@bloomberg.net, David Scanlan, Kristine OwramFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • CNW Group

    Curaleaf Announces September Conference Attendance

    WAKEFIELD, Mass. , Sept. 10, 2019 /CNW/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States , today announced its management will ...

  • U.S. Marijuana Sales Will Be 12 Times Higher Than Canada by 2024, Report Shows
    Motley Fool

    U.S. Marijuana Sales Will Be 12 Times Higher Than Canada by 2024, Report Shows

    North American cannabis sales are set to surpass $47 billion in less than five years, according to Prohibition Partners.

  • These U.S. Pot Stocks Are a Bargain, According to This 69-Year-Old Investment Bank
    Motley Fool

    These U.S. Pot Stocks Are a Bargain, According to This 69-Year-Old Investment Bank

    Three vertically integrated multistate operators look attractive to Canaccord Genuity.

  • These 3 States Will Begin Selling Recreational Pot Fairly Soon
    Motley Fool

    These 3 States Will Begin Selling Recreational Pot Fairly Soon

    Two of these three states should be billion-dollar cannabis markets by 2024.

  • Market Exclusive

    Cannabis Stock News Daily Roundup September 4

    Cannabis technology firm Weedmaps is now partnering with Cova Software, a cannabis retail point-of-sale, to deliver improved real-time online menu integration. The newly-upgraded Weedmaps platform will allow medical dispensaries and recreational cannabis stores using Cova's POS system to sync inventory online automatically. SugarBud Craft Growers (TSXV: SUGR) (OTC: RLLRF) has received cultivation, processing and medical sales licenses from […]The post Cannabis Stock News Daily Roundup September 4 appeared first on Market Exclusive.

  • Curaleaf Opens 49th Dispensary; Stock Rises Almost 8%
    Motley Fool

    Curaleaf Opens 49th Dispensary; Stock Rises Almost 8%

    The company's latest retail outlet is located in Port Charlotte, Florida.

  • Is Curaleaf a Good Cannabis Stock to Buy Now?
    Motley Fool

    Is Curaleaf a Good Cannabis Stock to Buy Now?

    The company has some bold predictions for the year ahead that could make investors very rich.

  • Why Curaleaf Holdings (CNSX:CURA) Rose 10% in the Last Week
    The Motley Fool

    Why Curaleaf Holdings (CNSX:CURA) Rose 10% in the Last Week

    Why it's advisable to buy Curaleaf Holdings Inc (CNSX:CURA) at the current price.

  • CNW Group

    Curaleaf Opens Port Charlotte's Largest Medical Cannabis Center

    PORT CHARLOTTE, Fla., Sept. 3, 2019 /CNW/ -- Curaleaf Holdings, Inc. (CSE:CURA.CN - News) (OTCQX:CURLF - News) ("Curaleaf" or the "Company"), a leading vertically integrated cannabis operator in the United States, announced today the opening of its 26th Florida dispensary at 1944 Kings Highway in Port Charlotte. Curaleaf has the largest cannabis dispensary footprint in the US with 49 dispensaries across the country, and continues to execute on its strategy of rapid expansion in Florida.

  • Cannabis Investors: 2 Stocks That Could Dominate Retail
    The Motley Fool

    Cannabis Investors: 2 Stocks That Could Dominate Retail

    Fire & Flower Holdings Corp (TSX:FAF) secured a big investor earlier this month, which could help the company solidify a strong leadership position in the industry.

  • Is This U.S. Pot Stock the New Industry Leader?
    The Motley Fool

    Is This U.S. Pot Stock the New Industry Leader?

    Canopy Growth Corp (TSX:WEED)(NYSE:CGC) may have been the dominant name in the cannabis industry thus far, but that might not be the case for much longer.